Literature DB >> 19402572

An unusual case of 4-aminopyridine toxicity in a multiple sclerosis patient: epileptic disorder or toxic encephalopathy?

H De Cauwer1, Ph De Wolf, F Couvreur, L Mortelmans.   

Abstract

We report the case of a 45-year old female multiple sclerosis patient, who accidentally was overdosed with 4-aminopyridine which resulted in dystonic, choreathetoid type abnormal movements in the four limbs, motoric distress, confusion and opisthotonus. There is little known about 4-aminopyridine toxicity. There are only a few reported cases ranging from mild paresthesias to tonic-clonic seizures. 4-aminopyridine enhances neuronal conduction at neuromuscular synapses and is indicated in the treatment of selected neurological disorders including multiple sclerosis (MS) and myasthenia gravis, among others.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19402572

Source DB:  PubMed          Journal:  Acta Neurol Belg        ISSN: 0300-9009            Impact factor:   2.396


  5 in total

Review 1.  [4-Aminopyridine (Fampridine). A new attempt for the symptomatic treatment of multiple sclerosis].

Authors:  L Husseini; V I Leussink; B C Kieseier; H-P Hartung
Journal:  Nervenarzt       Date:  2010-02       Impact factor: 1.214

2.  Pediatric Acute Toxic Leukoencephalopathy: Prediction of the Clinical Outcome by FLAIR and DWI for Various Etiologies.

Authors:  K Ozturk; J Rykken; A M McKinney
Journal:  AJNR Am J Neuroradiol       Date:  2020-07-02       Impact factor: 3.825

Review 3.  4-aminopyridine toxicity: a case report and review of the literature.

Authors:  Andrew M King; Nathan B Menke; Kenneth D Katz; Anthony F Pizon
Journal:  J Med Toxicol       Date:  2012-09

Review 4.  Restoring Axonal Function with 4-Aminopyridine: Clinical Efficacy in Multiple Sclerosis and Beyond.

Authors:  Verena Isabell Leussink; Xavier Montalban; Hans-Peter Hartung
Journal:  CNS Drugs       Date:  2018-07       Impact factor: 5.749

5.  Prolonged Toxic Encephalopathy following Accidental 4-Aminopyridine Overdose.

Authors:  Maria Ballesta Méndez; Vincent van Pesch; Arnaud Capron; Philippe Hantson
Journal:  Case Rep Neurol Med       Date:  2014-04-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.